GlassScriptPhysician profile
Richard Vangrouw
NPI 1306827571
$1,240.25
in general payments reported to CMS, 2019-2025
18 companies · $57.11 in 2025
The $57.11 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $55.82 · 2021: $13.95 · 2022: $197 · 2023: $403 · 2024: $357 · 2025: $57.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $479.31 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $161.91 | 2021-2024 | Selectsecure, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Pfizer INC. | $122.02 | 2019-2024 | |
| Medtronic Vascular, INC. | $115.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $66.70 | 2022-2024 | |
| Boston Scientific Corporation | $52.74 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $42.39 | 2022-2023 | Opsumit |
| Abiomed | $32.25 | 2019 | |
| Merck Sharp & Dohme LLC | $20.92 | 2024 | Verquvo |
| Philips North America LLC | $19.30 | 2024 | (6536) Phoenix |
| Edwards Lifesciences Corporation | $19.21 | 2024 | Sapien 3 Ultra Resilia |
| Silk Road Medical, INC. | $17.74 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cvrx, INC. | $16.93 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $16.58 | 2024 | Xarelto |
| Convatec INC. | $16.39 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $13.78 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.55 | 2025 | |
| Cardiovascular Systems INC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Vangrouw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.